Expert Opinion on Pharmacotherapy

The failure of torcetrapib: is there a case for independent preclinical and clinical testing?
pp. 875-878(4)
Author: Doggrell, Sheila A

Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft
pp. 879-886(8)
Authors: Neumann, Irmgard; Fuhrmann, Heinz; Kanzler, Marina; Fang, I-Fei; Jaeger, Adelheid; Graf, Helmut; Bayer, Peter; Kovarik, Josef

Neuroprotectants in stroke therapy
pp. 887-900(14)
Authors: Jeyaseelan, K; Lim, KY; Armugam, A

Haemorrhagic shock therapy
pp. 901-911(11)
Authors: Anjaria, Devashish J; Mohr, Alicia M; Deitch, Edwin A

Pharmacotherapy of atrial fibrillation: an old option with new possibilities
pp. 913-925(13)
Authors: Janko, Sabine; Dorwarth, Uwe; Hoffmann, Ellen

Fungicidal versus Fungistatic: what's in a word?
pp. 927-935(9)
Authors: Lewis, James S; Graybill, John R

Pharmacotherapy of bone metastases in breast cancer patients
pp. 937-945(9)
Authors: Petrut, Bianca; Simmons, Christine; Broom, Reuben; Trinkaus, Mateya; Clemons, Mark

Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism
pp. 947-954(8)
Authors: Cozzolino, Mario; Brancaccio, Diego

Pharmacotherapy of acne
pp. 955-971(17)
Authors: Degitz, Klaus; Ochsendorf, Falk

Therapeutic management of psychodermatological disorders
pp. 973-985(13)
Author: Shenefelt, Philip D

Pharmacoeconomics of linezolid
pp. 987-1000(14)
Authors: Grau, Santiago; Rubio-Terrés, Carlos

A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future
pp. 1001-1011(11)
Author: Mannix, Lisa K

Zoledronic acid for cancer therapy-induced and postmenopausal bone loss
pp. 1013-1028(16)
Author: Brufsky, Adam M

Homoharringtonine for the treatment of chronic myelogenous leukemia
pp. 1029-1037(9)
Authors: Quintás-Cardama, Alfonso; Cortes, Jorge

Tibolone: the way to beat many a postmenopausal ailments
pp. 1039-1047(9)
Authors: Lazovic, Gordana; Radivojevic, Ubavka; Marinkovic, Jelena

MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis
pp. 1049-1058(10)
Authors: Hu, Mary Y; Peppercorn, Mark A

Travoprost/timolol fixed combination
pp. 1059-1065(7)
Authors: Herceg, Michael; Noecker, Robert